Adoptive Cell Therapy 1

• 3699 · PDF The "Preservation & Expansion" process: A key milestone for enhancing accessibility of autologous tumor-infiltrating lymphocyte therapy by enabling long-term cryopreservation of seed cells Zhou He, Xingming Ma, Feng Yin, Shanshan Liang, Wenjia Zhuang, Hui Yan, Huajun Jin
• 3700 · PDF Engineering iPSC-derived NK cells with autocrine feeder signaling to enhance cytotoxic function Yi-Chen Sun, Zhi-Qian Lin, Chieh-Min Ｗang, Yun-Yi Yang, Yi-Ping Yang, Kai-Feng Hung
• 3701 · PDF Safety and efficacy of CAR T-cell therapy in CNS lymphoma: A meta-analysis Ahmad Shawabkeh, Muaath I. Alsufi, Homam AbuHashesh, Heba Khreisat, Zaid Muhanna, Salma Salman, Ahmad Obeid, Layan AlDaher, Jehad Yasin
• 3702 · PDF No impact of dexamethasone on CAR-T cell expansion in vitro and in patients with RRMM Lelisa Gemta, Lawrence P. Andrews, Matthew J. Frigault, Binod Dhakal, Jacalyn Rosenblatt, Michael R. Bishop, Sigal Shachar, Jenny Mu
• 3703 · PDF Sentinel lymph node-derived CD45⁺ cells combined with low-dose radiotherapy and PD-1 blockade as a next-generation adoptive cell therapy in head and neck cancer Pardis Mohammadzadeh, Tomoya Kurokawa, Kelsey Decker, Peter Vo, Prakriti Sen, Riley N. Jones, Sayuri Miyauchi, Santiago Fassardi, Anais Zourelidis, Robert Saddawi-Konefka, Joseph A. Califano
• 3704 3704 Long-term ex vivo expansion of functional CAR-T cells using the biomimetic AeroCyte-based artificial antigen-presenting cell platform Yu-Tsueng Liu, Mindy Yin, Guixin Shi
• 3705 · PDF Integration of affinity-dependent modulation and CD5/TRAC knockout generates fratricide-resistant and highly cytotoxic anti-CD5 CAR-T cells Seojeong Kim, Jeong Hoon Jeong, Jihyun Park, Youngho Lee, Hyung Cheol Kim, Hyoung Jin Kang, Matthew H. Porteus, Steven Feldman, Youngil Koh
• 3706 · PDF Impact of number of IL-2 infusions and product out of specification status on outcomes of tumor infiltrating lymphocyte therapy for melanoma Mohamed A. Aboelatta, Jeffrey E. Johnson, Jabra G. Zarka, Matyáš Benada, James W. Jakub, Roxana S. Dronca, Ruqin Chen, Mahesh Seetharam, Deepti Behl, Svetomir N. Markovic, Lisa A. Kottschade, Heather N. Montane, Matthew S. Block, Anastasios Dimou, Robert R. McWilliams, Paula Gill, Yi Lin, Arkadiusz Z. Dudek
• 3707 · PDF Durable remission of high-risk and refractory neuroblastoma by PHOX2B derived peptide-HLA directed CAR T cells: An IND enabling study Muzamil Y. Want, Richa Kapoor, David Groff, Keelan O’Reilly, Liron Grossmann, Alvin Farrel, Rebeca A. Ventura, Peiyao Li, Quinlen Marshall, Jenny pogoriler, Daniel Martinez, Matt Beasley, Ben Kiefel, Mark Yarmarkovich, John Maris
• 3708 · PDF Improving antitumor T cell therapy with membrane-tethered engineered cytokine agonists Diana Gumber, Saul Priceman, Christine E. Brown, Leo D. Wang
• 3709 · PDF A first-in-class Erythrocyte-anti-PD-1 conjugate overcomes immunotherapy resistance across pan-solid tumors: A phase I trial Xiaoqian Nie, Liu Yang, Kurban Mattursun, Zheling Chen, Xiaofei Gao
• 3710 · PDF Adapting and validating a humanized mouse model for testing of immune-shielded genetic modifications in therapeutic cells Mino Yakoub, Katrin Ridders, Henning Jelten, Audrey Holtzinger, Matthias Austen, Claudia Wrzos
• 3711 · PDF Enriching CD8+ and CD4+ neoantigen-reactive tumor infiltrating lymphocytes by cell surface marker-based sorting Lisa M. Kenney, Nivedita Ratnam, Abraham A. Hakim, Juliette Rault-Wang, Steven A. Rosenberg, Frank J. Lowery
• 3712 · PDF Pleiotropic oxidized carbon nanozymes reprogram CAR T cell metabolism to enhance persistence through redox modulation Kevin Song, Yue Hu, Paul Derry, Thomas Kent, Xiaotong Song
• 3713 · PDF Fluorescence potency assays for evaluating HER2 CAR T-cell-mediated killing in cancer cells Danny Flanigan, Nathalie Opdam - van de Laar, Denise Sullivan, DANIEL MILLARD, STACIE CHVATAL
• 3714 · PDF Immunopeptidomic discovery of fetal WNT-associated antigen NKD1 enables HLA-A2+ restricted TCR-T therapy for MSS mCRC Jaeyop Lee, Swara Patel, Iñaki Etxeberria, Elizabeth Benitez, Jura Pintar, Andres Rettig, Christopher Cowley, Stefanie Gerstberger, Kathleen Luckett, Asha Saxena, Zita Aretz, Tatyana Korontsvit, Zhuoning Li, Kevin Soares, Emmanouil Pappou, T. Peter Kingham, William Jarnagin, Philip B. Paty, Martin R. Weiser, Michael D’Angelica, Julio Garcia-Aguilar, Jinru Shia, Mara Monetti, Christopher A. Klebanoff, Karuna Ganesh, David A. Scheinberg
• 3715 · PDF Epigenetic and signaling-based engineering enhances CAR-T cell function in oculo-cerebral lymphoma Marion Alcantara, Jaime Fuentealba, Silvia Menegatti, Anne-Laure Privat, Lisseth Silva, Kyle Raymond, Daniel De Murat, Valentine Pottez Jouatte, Lamia Lamrani, Zélia Gouveia, Denis Malaise, Carole Soussain, Sebastian Amigorena
• 3716 · PDF Regulatory immunotherapy utilizing activated natural killer cells and antitumor response for hepatocellular carcinoma Ola Sayed Ahmed, Refaat Gabre, Amr Iamail Abdelraouf, Hisham Imam, Maha Genhia
• 3717 · PDF DLL3-targeted in vivo CAR-T therapy of small cell lung cancer with lipid nanoparticles and circular RNA Yishan Ma, Jingsheng Cai, Yufei Xia, Xiaonan Huang, Mantang Qiu
• 3718 · PDF CAR Detection Reagents - Pioneering advances in CAR T analytics Stephan Wilmes, Desiré Missing, Anja Brauchle, Nadine Borgelt, Johanna Müllers, Monika Winkels, Larissa Möckel, Michaela Niemöller, Dagmar Häußler-Kuballa, Franziska Antonia Bertram, Olga Goldbach, Dominik Poschen, Astrid Imann, Silvia Rüberg, Anijutta Appelshoffer, Fabio El Yassouri, Marsilius Mues, Volker Nölle, Andreas Bosio, Christian Dose, Anne Richter
• 3719 · PDF From gene to bedside: Mayo Clinic's first-in-house BAFF-R CAR-T Yan Luo, Shaohua Guo, Yaqing Qie, Martha E. Gadd, Tanya Hundal, Hemant S. Murthy, Mohamed A. Kharfan-Dabaja, Hong Qin
• 3720 · PDF Nectin-4-targeted CAR-NK cells exhibit potent antitumor activity against bladder cancer Mohammad Mousaei Ghasroldasht, Piyush K. Agarwal
• 3721 · PDF Anti-tumor function and long-term persistence of KSQ-001EX, a SOCS1-edited eTIL® therapy, independent of IL-2 co-administration Dipen Sangurdekar, Erica Tobin, Karrie Wong, Ashish Yeri, Alex Smashnov, Kelly Bowen, Giorgio Sarkis, Violetta Medik, Hsinyi Lu, Sevinj Isgandarova, Michelle Carrasco, Patricia Harris, Cara L. Haymaker, Micah Benson, Anna Truppel-Hartmann, Rodabe N. Amaria
• 3722 · PDF Preclinical development and evaluation of CD87-directed CART for colorectal cancer Andrea Feci, Trevor Baybutt, Robert Carlson, Emmett Grover, Jagmohan Singh, Ross Staudt, Miao Cao, Edoardo Manca, Jasmine Alvarez, Scott A. Waldman, Adam Snook
• 3723 · PDF Evaluation of ex vivo CAR-T cell cytotoxicity and infiltration using multimodal 2-D and 3-D imaging approaches Catherine McManus, John G. Foulke, Meghan Sikes, Luping Chen, Hyeyoun Chang, Fang Tian
• 3724 · PDF Exogenous IL-2 administration promotes circulating T-cell levels, persistence and therapeutic efficacy of allogeneic UCART20x22 in a B-cell lymphoma mouse model Shipra Das, Hana Cho, Marco Rotondi, Isabelle Chion-Sotinel, Margaux Sevin, Vivian Dai, Jean-Charles Epinat, Roman Galetto, Laurent Poirot, Adrian Kilcoyne
• 3725 · PDF Stem cell-derived allogeneic anti-CD19 CAR-iNKT cell therapy GT719 for relapsed/refractory B cell malignancies Dehui Zou, Wei Liu, Yan Yu, Huimin Liu, Yi Wang, Sisi Feng, Xiaona Xu, He Zhang, Ershao Zhang, Jiang Li, Jingman Wang, Jing Hao, Ning Wang, Huipin Zheng, Yin Cheng, Jun Cui, Jingwei Sun, Yarong Liu

在会议检索中浏览本分会场